Ardent Health Income Statement (2023-2026) | ARDT

1Y3Y5Y7Y10YAll
Download Data
Income Statement Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue (Quarter) 1,368.73M1,377.73M1,346.03M1,439.05M1,470.92M1,449.82M1,606.29M1,497.23M1,645.28M1,576.75M1,605.08M1,601.87M1,622.24M
Cost of Revenue (Quarter) 108.83M249.55M651.38M121.83M259.39M117.70M141.37M258.86M270.64M198.71M277.53M268.55M279.62M
Gross Profit (Quarter) 1,259.90M1,128.18M694.65M1,317.21M1,211.53M1,332.12M1,464.92M1,238.38M1,374.64M1,378.03M1,327.55M1,333.32M1,342.62M
Operating items
Other Operating Expenses (Quarter) 1,275.51M1,307.25M1,312.99M1,357.63M1,363.75M1,366.34M1,411.72M1,384.99M1,495.46M1,540.84M1,441.78M1,488.59M1,540.36M
Operating Expenses (Quarter) 1,300.92M1,331.76M1,337.21M1,382.48M1,388.74M1,392.75M1,439.04M1,423.04M1,523.29M1,578.95M1,512.71M1,527.28M1,579.04M
Operating Income (Quarter) -41.01M-203.58M-642.55M-65.27M-177.21M-60.63M25.88M-184.66M-148.65M-200.92M-185.16M-193.96M-236.42M
EBIT (Quarter) -41.01M-203.58M-642.55M-65.27M-177.21M-60.63M25.88M-184.66M-148.65M-200.92M-185.16M-193.96M-236.42M
Non-operating items
Interest & Investment Income (Quarter) 0.52M1.09M0.26M2.81M23.20M21.28M-0.56M2.60M5.89M
Other Non Operating Income (Quarter) -1.90M-1.49M-7.34M
Net income details
EBT (Quarter) 67.82M45.97M8.83M56.56M82.18M57.07M167.25M74.20M121.99M-2.20M92.37M74.59M43.20M
Tax Provisions (Quarter) 12.10M7.26M-1.95M10.71M15.22M11.10M26.36M15.23M26.29M-3.40M18.12M16.10M8.51M
Profit After Tax (Quarter) 33.08M38.71M70.92M27.05M42.77M26.32M114.20M41.38M72.95M1.21M74.26M39.85M34.69M
Income from Non-Controlling Interests (Quarter) 22.63M17.87M14.93M18.80M24.19M19.68M26.69M17.58M22.75M24.68M29.31M18.64M17.79M
Income from Continuing Operations (Quarter) 55.72M38.71M10.78M45.85M66.96M45.97M140.89M58.97M95.70M1.20M74.25M58.49M34.69M
Consolidated Net Income (Quarter) 55.72M38.71M10.78M45.85M66.96M45.97M140.89M58.97M95.70M1.20M74.25M58.49M34.69M
Income towards Parent Company (Quarter) 55.72M38.71M10.78M45.85M66.96M45.97M140.89M58.97M95.70M1.20M74.25M58.49M34.69M
Net Income towards Common Stockholders (Quarter) 55.72M38.71M10.78M45.85M66.96M45.97M140.89M58.97M95.70M1.20M74.25M58.49M34.69M
Additional items
EPS (Basic) (Quarter) 0.440.310.090.360.530.341.060.420.680.010.530.410.24
EPS (Diluted) (Quarter) 0.440.310.090.360.530.331.060.420.680.010.520.410.24
Shares Outstanding (Quarter) 126.12M126.12M126.12M126.12M126.12M137.11M132.44M140.06M140.37M141.23M140.76M141.27M141.69M
Shares Outstanding (Diluted) (Quarter) 126.12M126.12M126.12M126.12M126.12M137.54M132.74M140.70M141.52M141.23M141.45M141.78M143.05M
Shares Outstanding (Entity) (Quarter) 126.12M126.12M126.12M126.12M126.12M137.11M142.75M143.04M143.10M143.17M142.86M143.13M141.91M
EBITDA (Quarter) -41.01M-203.58M-642.55M-65.27M-177.21M-60.63M25.88M-184.66M-148.65M-200.92M-185.16M-193.96M-236.42M
Interest Expenses (Quarter) 18.69M19.04M-12.05M19.26M18.16M14.63M29.38M14.60M14.73M13.91M8.78M15.50M13.40M
Tax Rate (Quarter) 17.84%15.80%-22.14%18.94%18.52%19.45%15.76%20.53%21.55%154.33%19.62%21.59%19.71%